Treating asthma and COPD patients brings various benefits, such as better quality of life for patients and their families, higher output as a result of fewer days lost to sickness, and lower healthcare costs thanks to the improvement in patients’ health. Merely treating asthma patients with inflammation inhibitors yields social benefits of 127 million euros a year. This is the finding of research carried out by SEO Economic Research for De Long Alliantie Nederland.
Researchers Lucy Kok
Publication date 01-01-2013
Publication number 2013-46
Area of expertise Healthcare
Commissioned by Long Alliantie Nederland
Published by SEO Economic Research
Publication type Report
Do you have any questions about this publication?
Feel free to contact Lucy Kok via e-mail or phone. She will respond to your questions as soon as possible.
"*" indicates required fields